Genmab’s Stellar Cancer-Drug Data Fuels Stock’s $10 Billion Week It’s been a breakout week for Danish biotech Genmab A/S. By Margaryta Kirakosian · Bloomberg Markets It’s been a breakout week for Danish biotech Genmab A/S.